Schrag D - Search Results

1

Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy.

Judson TJ, Bennett AV, Rogak LJ, Sit L, Barz A, Kris MG, Hudis CA, Scher HI, Sabattini P, Schrag D, Basch E. Judson TJ, et al. Among authors: schrag d. J Clin Oncol. 2013 Jul 10;31(20):2580-5. doi: 10.1200/JCO.2012.47.6804. Epub 2013 Jun 3. J Clin Oncol. 2013. PMID: 23733753 Free PMC article.

2

Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare.

Schrag D, Gelfand SE, Bach PB, Guillem J, Minsky BD, Begg CB. Schrag D, et al. J Clin Oncol. 2001 Sep 1;19(17):3712-8. doi: 10.1200/JCO.2001.19.17.3712. J Clin Oncol. 2001. PMID: 11533092

3

Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer.

Schrag D, Rifas-Shiman S, Saltz L, Bach PB, Begg CB. Schrag D, et al. J Clin Oncol. 2002 Oct 1;20(19):3999-4005. doi: 10.1200/JCO.2002.11.084. J Clin Oncol. 2002. PMID: 12351597

4

Use of information resources by patients with cancer and their companions.

Basch EM, Thaler HT, Shi W, Yakren S, Schrag D. Basch EM, et al. Among authors: schrag d. Cancer. 2004 Jun 1;100(11):2476-83. doi: 10.1002/cncr.20261. Cancer. 2004. PMID: 15160355 Free article.

5

Use of surgery among elderly patients with stage IV colorectal cancer.

Temple LK, Hsieh L, Wong WD, Saltz L, Schrag D. Temple LK, et al. Among authors: schrag d. J Clin Oncol. 2004 Sep 1;22(17):3475-84. doi: 10.1200/JCO.2004.10.218. J Clin Oncol. 2004. PMID: 15337795

6

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

Chung KY, Shia J, Kemeny NE, Shah M, Schwartz GK, Tse A, Hamilton A, Pan D, Schrag D, Schwartz L, Klimstra DS, Fridman D, Kelsen DP, Saltz LB. Chung KY, et al. Among authors: schrag d. J Clin Oncol. 2005 Mar 20;23(9):1803-10. doi: 10.1200/JCO.2005.08.037. Epub 2005 Jan 27. J Clin Oncol. 2005. PMID: 15677699

7

An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer.

Schrag D, Weiser M, Schattner M, Shia J, Akhurst T. Schrag D, et al. J Clin Oncol. 2005 Mar 20;23(9):1799-802. doi: 10.1200/JCO.2005.02.185. J Clin Oncol. 2005. PMID: 15774773 No abstract available.

8

Patient online self-reporting of toxicity symptoms during chemotherapy.

Basch E, Artz D, Dulko D, Scher K, Sabbatini P, Hensley M, Mitra N, Speakman J, McCabe M, Schrag D. Basch E, et al. Among authors: schrag d. J Clin Oncol. 2005 May 20;23(15):3552-61. doi: 10.1200/JCO.2005.04.275. J Clin Oncol. 2005. PMID: 15908666

9

The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999.

Elkin EB, Hudis C, Begg CB, Schrag D. Elkin EB, et al. Among authors: schrag d. Cancer. 2005 Sep 15;104(6):1149-57. doi: 10.1002/cncr.21285. Cancer. 2005. PMID: 16088887 Free article.

10

Missed opportunities: racial disparities in adjuvant breast cancer treatment.

Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, Mendez J, Guth AA. Bickell NA, et al. Among authors: schrag d. J Clin Oncol. 2006 Mar 20;24(9):1357-62. doi: 10.1200/JCO.2005.04.5799. J Clin Oncol. 2006. PMID: 16549830

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

440 results

Search Page